Education
About Us
Working with TipRanks
Follow Us
Apogee Therapeutics (APGE)
NASDAQ:APGE
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -216.87M | $ -93.00M | $ -30.73M |
| EBITDA | $ -216.68M | $ -74.97M | $ -39.78M |
| Net Income | $ -182.15M | $ -83.98M | $ -39.78M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 520.65M | $ 395.46M | $ 151.89M |
| Total Assets | $ 753.95M | $ 401.40M | $ 152.06M |
| Total Debt | $ 11.83M | $ 2.03M | $ 0.00 |
| Net Debt | $ -129.96M | $ -116.28M | $ -151.89M |
| Total Liabilities | $ 37.16M | $ 21.49M | $ 9.98M |
| Stockholders' Equity | $ 716.79M | $ 379.91M | $ 142.07M |
| Cash Flow | |||
| Free Cash Flow | $ -172.33M | $ -74.93M | $ -16.43M |
| Operating Cash Flow | $ -171.17M | $ -74.76M | $ -16.43M |
| Investing Cash Flow | $ -300.46M | $ -273.91M | $ 0.00 |
| Financing Cash Flow | $ 495.11M | $ 315.39M | $ 168.32M |